Proof-of-concept for V600E BRAF mutation as a therapeutic target in human cancer..Melanoma..Jim Breitfeller

Proof-of-concept for V600E BRAF mutation as a therapeutic target in human cancer

Phase 1 study of PLX4032: Proof-of-concept for V600E BRAF mutation as a therapeutic target in human cancer”
Oral presentation to be made on June 1, 2009, 4:30 p.m. to 6:00 p.m. EDT by Keith T. Flaherty, assistant professor, University of Pennsylvania Abramson Cancer Center, in the “Molecular Phenotype of Melanoma Subtypes and Patient-Specific Therapy” session

Link to video clip of Dr. Flaherty


We just may be getting a handle on this deadly disease!!!!!!!!!


Take care

Jimmy B